Oncology Views & News

Views and news in clinical oncology, research, cancer prevention, patient care and more.

Labels

  • ASCO15
  • Hematology Malignancies
  • GI Cancers
  • Lung Cancer
  • Breast Cancer
  • Cancer China
  • Biomarkers
  • Immunotherapy
  • EHA15
  • NCCN15
  • China Cancer Drugs
  • ELCC15
Showing posts with label EHA15. Show all posts
Showing posts with label EHA15. Show all posts

Friday, June 26, 2015

  • New Agents Show Potential for Multiple Myeloma; Transplant Remains 1st line--Dr. Sonneveld and Dr. Huang Discuss Highlights at EHA 2015


  • Bortezomib-based Combination, e.g. VMP, Probably the Most Efficient Regimen for Elderly Patients with Multiple Myeloma in Europe--Dr. Maria-Victoria Mateos's Interview at EHA 2015


    • Older Posts Home
    Subscribe to: Posts (Atom)

    Search This Blog

    Popular Posts

    • At ASCO 2015, Dr. Shi Meets with Dr. Lynch to Discuss about Highlights in Lung Cancer and Icotinib
    • Immunotherapy Breakthrough in Advanced Melanoma Treatment, Biomarker Lacks--Dr. Jun Guo Discusses LBA1 at ASCO 2015
    • Target Therapy or Missed Target Therapy in Lung Cancer New Data? --Commentaries from Dr. Yi-Long Wu at ASCO 2015
    • Chinese Cancer Patients are Seeking the Best Chance for Cure, Globally
    • How to Overcome Drug Resistance to Target Therapy in Non Small Cell Lung Cancer?--Dr. Leona Horn's Interview at NCCN 2015

    Translate

    Blog Archive

    • ▼  2015 (42)
      • ▼  July (13)
        • Updates in the treatment of peripheral T cell lymp...
        • Sentinel Lymph Node Biopsy(SNB) in Early Stage Bre...
        • Peritoneal Metastasis in Colorectal Cancer Patient...
        • Predictive Factors More Important in Relapsed/Refr...
        • "China Primary Lung Cancer Diagnosis and Treatment...
        • PEG10, One LncRNAs, A Possible Biomarker/Target fo...
        • Afatinib Activities Different in Uncommon EGFR Mut...
        • Molecular Target Therapy for Brain Metastases in N...
        • Response to Chemo/Radiation Therapy of Prognostic ...
        • To WBRT, or Not WBRT in Brain Metastasis?--Dr. Jin...
        • Choices for Relapsed or Refractory Multiple Myelom...
        • Micro-RNAs, the Potential Biomarkers for Early Det...
        • MRD test, The Next Big Thing in Multiple Myeloma--...
      • ►  June (17)
      • ►  April (1)
      • ►  March (4)
      • ►  February (7)

    About Me

    Oncology China
    Views and news in clinical oncology, research, cancer prevention, patient care and more.
    View my complete profile

    Disclaimer

    The blog is designed primarily for use by qualified physicians, other medical professionals, researchers and scientists in oncology field. The information contained herein should NOT be used as anyway a substitute for the advice of a licensed physician or other licensed health care provider. The information provided here is for informational and educational purposes only. In no way should it be considered as offering medical advice. Please check with your physician for any consultation. All opinions expressed by quoted sources are their own and do not necessarily reflect the opinions of the author(s) of this blog. While every effort has been made to provide up to date, accurate information and in depth analysis, your view of this blog is solely at your own risk if you make any decisions based on the information in this blog. The blog may keep updating old posts and is not bound to explain or state any changes made.

    Total Pageviews
    Simple theme. Powered by Blogger.